ConvaTec Group (CTEC.L) Osake Kurssi

ConvaTec Group PLC is primarily active in the healthcare industry.

The main competitors of ConvaTec Group PLC in the market are Coloplast A/S, Medtronic plc, and Hollister Incorporated.

ConvaTec Group PLC is a well-established global medical products and technologies company. Founded in 1978, it has a rich and extensive history in the healthcare industry. ConvaTec specializes in developing and manufacturing innovative medical devices, including advanced wound care, ostomy care, continence and critical care products. With headquarters in the UK, ConvaTec operates in over 100 countries, serving healthcare professionals and patients worldwide. Over the years, ConvaTec has earned a strong reputation for its high-quality products, commitment to research and development, and dedication to improving patient lives. As a leading player in the medical industry, ConvaTec Group PLC continues to strive for excellence and innovation in healthcare solutions.

ConvaTec Group PLC has achieved several significant milestones throughout its history. Some notable achievements include the company's initial public offering (IPO) in 2016, which marked a major milestone in its growth and development. Additionally, ConvaTec has successfully introduced innovative products and solutions in the healthcare industry, such as its advanced wound care products, ostomy care solutions, and continence and critical care products. The company has also expanded its global footprint by establishing a strong presence in various geographical markets, providing healthcare solutions to a wide range of patients worldwide. ConvaTec's commitment to continuous innovation, product development, and global expansion has contributed to its success and reputation in the healthcare industry.

ConvaTec Group PLC is primarily present in various countries and regions worldwide. As a global company, its operations span across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. With a strong international presence, ConvaTec serves customers and patients in numerous countries, including the United States, Canada, United Kingdom, Germany, France, Italy, Spain, Australia, China, Japan, and many more. By establishing a diverse and extensive geographic footprint, ConvaTec aims to provide its innovative healthcare products and solutions to a broad range of individuals, healthcare professionals, and healthcare systems around the world.

ConvaTec Group PLC represents a strong set of values and a customer-centric corporate philosophy. With a focus on improving the lives of patients, ConvaTec is committed to delivering innovative medical products and solutions. They aim to provide high-quality, reliable, and advanced healthcare technologies that meet the diverse and evolving needs of individuals. By leveraging their expertise and collaborative approach, ConvaTec aims to drive positive healthcare outcomes and enhance patient experiences. With a global presence and a dedicated team, they continuously strive to make a difference in the healthcare industry, emphasizing integrity, innovation, and compassion.

21 analyytikkoa arvioi tällä hetkellä ConvaTec Group-osaketta: 19 suosittaa ostoa, 2 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat ConvaTec Group-yhtiöltä 2,55 Mrd. USD liikevaihtoa ja 0,00 USD osakekohtaista tulosta.

ConvaTec Group Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla ConvaTec Group-osake noteerataan hintaan 3,09 EUR (3,41 USD).

ConvaTec Group-osake (CTEC.L) on listattuna 7 pörssissä, muun muassa: London (CTEC.L), SIX (Zürich) (2CV.SW), Frankfurt (2CV.F), München (2CV.MU), Düsseldorf (2CV.DU).

The ConvaTec Group PLC is a British company specializing in medical products and services. It offers a wide range of products in four business areas: ostomy products, continence and intimate hygiene products, wound therapeutics, and infusion and respiratory products. Ostomy Products ConvaTec offers a comprehensive range of ostomy products for people with intestinal diseases such as colon cancer, Crohn's disease, or ulcerative colitis. The products are developed in close collaboration with patients and healthcare professionals to ensure the best fit and user-friendliness. Continence and Intimate Hygiene Products ConvaTec also produces products for continence and intimate hygiene, such as diapers, pads, and skincare products. These products are designed for patients with urinary or fecal incontinence, as well as for people with limited mobility. Wound Therapeutics The wound therapeutics business area includes a wide range of products for wound care, including compression bandages, foam and hydrocolloid dressings, alginates, and silicone gels. These products are used to treat wounds such as pressure ulcers, venous leg ulcers, and surgical wounds. Infusion and Respiratory Products The infusion and respiratory products business area offers a wide range of medical products used in the treatment of lung diseases such as COPD, asthma, and pneumonia. These products include inhalers, oxygen therapy devices, and infusion devices. Additional Services ConvaTec also provides services such as training for healthcare professionals and patients. These trainings cover various areas, including stoma care, wound care, and continence management. Additionally, the company offers consulting services for healthcare professionals. Business Model ConvaTec achieves its business model by identifying needs and challenges in the healthcare industry and developing and manufacturing innovative products and services. The company works closely with healthcare professionals and patients to ensure that the products meet the users' requirements and needs. The company also focuses on a strong presence in the global market, facilitated by strategic acquisitions and partnerships. ConvaTec has offices and distribution centers in over 100 countries worldwide and employs over 9,000 people. Furthermore, ConvaTec places great emphasis on research and development and invests in the development of new products and technologies. The company collaborates closely with universities and research institutions to support its research and development activities. Overall, ConvaTec's business model is focused on developing and globally distributing innovative products and services to meet the needs of healthcare professionals and patients, thereby improving the health and well-being of millions of people.

odotettu liikevaihto ConvaTec Group on 2,55 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto ConvaTec Group on 5,46 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

ConvaTec Group:n hinta-voitto-suhde (P/E) on tällä hetkellä 1 254,57. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan ConvaTec Group-osakkeen arvostusta.

ConvaTec Group:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,68. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii ConvaTec Group-osakkeen arvostuskennuslukuna.

ConvaTec Group:n Eulpool-laatuscore on 5/10.

ConvaTec Group:n ISIN on GB00BD3VFW73. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

ConvaTec Group:n WKN on A2AUD3. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

ConvaTec Group:n ticker on CTEC.L. Tämä pörssinoteeraus käytetään ConvaTec Group-osakkeiden kauppaan pörssissä.